SunRay DiFrancesco

Title: SunRay DiFrancesco: Innovator in Human Insulin-Like Growth Factor Research

Introduction

SunRay DiFrancesco is a notable inventor based in Peekskill, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of human insulin-like growth factor binding proteins. His innovative work has led to the creation of a patented solution that has potential applications in medical diagnostics and therapeutics.

Latest Patents

SunRay DiFrancesco holds a patent for a non-recombinant human insulin-like growth factor binding protein concentrate. This patent describes a human insulin-like growth factor (IGF) binding protein stock solution and a method for its production. The solution includes a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. Additionally, the patent includes a kit that features a set of calibrators for nr-IGFBP-3, which are provided in different concentrations.

Career Highlights

SunRay DiFrancesco is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to advance his research in the field of healthcare diagnostics. His work is instrumental in developing solutions that enhance the understanding and treatment of various medical conditions.

Collaborations

Some of his notable coworkers include Kwasi Osae-Kwapong and Michele Smith, who contribute to the collaborative efforts in research and development at Siemens Healthcare Diagnostics GmbH.

Conclusion

SunRay DiFrancesco's innovative contributions to the field of human insulin-like growth factor research exemplify the impact of dedicated inventors in advancing medical science. His patented work not only showcases his expertise but also holds promise for future advancements in healthcare diagnostics.